SPNE News and Press, SeaSpine Holdings Corporation From 04/18/19

CARLSBAD, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release first quarter 2019 financial results after the clos...

Financial highlights CHF 19.0 million cash & cash equivalents, trade and other receivables as at December 31, 2018 Net operating costs decreased to CHF 14.3 million Operational highlights First U.S. & European sales of MagnetOs Commercial rollout in the U.S....

Start Time: 16:30 End Time: 17:14 SeaSpine Holdings Corporation (SPNE) Q4 2018 Earnings Conference Call February 27, 2019, 16:30 PM ET Company Participants Keith Valentine - President and CEO John Bostjancic - SVP and CFO Carrie Mendivil - Director of IR Conference Call Pa...

SeaSpine (NASDAQ: SPNE ): Q4 GAAP EPS of -$0.53 misses by $0.16 . More news on: SeaSpine Holdings Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...

CARLSBAD, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, ...

CARLSBAD, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Kim Commins-Tzoumakas and Renee Gaeta as members of t...

CARLSBAD, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release fourth quarter and full year 2018 financial results ...

Global partner to market an advanced bone graft supplied by Kuros Agreement demonstrates interest of major orthobiologic companies in Kuros technologies SCHLIEREN (ZURICH), Switzerland, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) today announced that its Dutc...

CARLSBAD, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2018....

SeaSpine (NASDAQ: SPNE ): Q3 GAAP EPS of -$0.65 misses by $0.18 . More news on: SeaSpine Holdings Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...